OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 38 citing articles:

Inflammatory and vascular biomarkers in post‐COVID‐19 syndrome: A systematic review and meta‐analysis of over 20 biomarkers
Shin Jie Yong, Alice Halim, Michael Halim, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 2
Closed Access | Times Cited: 80

Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis
Tianqi Yang, Zhipeng Yan, Xingyi Li, et al.
Infection (2022) Vol. 50, Iss. 5, pp. 1067-1109
Open Access | Times Cited: 69

Endotheliopathy in Acute COVID-19 and Long COVID
Alice G. Vassiliou, Charikleia S. Vrettou, Chrysi Keskinidou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8237-8237
Open Access | Times Cited: 30

Post-acute sequelae of SARS-CoV-2 infection (Long COVID) in older adults
Samantha Russell, Karen Parker, Andrea Lehoczki, et al.
GeroScience (2024)
Closed Access | Times Cited: 9

Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6- and 12-months SARS-CoV-2 infection
Paula Poyatos, Neus Luque, Gladis Sabater, et al.
Infection (2024) Vol. 52, Iss. 4, pp. 1269-1285
Open Access | Times Cited: 8

Endothelial dysfunction and persistent inflammation in severe post-COVID-19 patients: implications for gas exchange
Enrique Alfaro, Elena Díaz‐García, Sara García-Tovar, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health
Mónika Fekete, Andrea Ceglédi, Ágnes Szappanos, et al.
GeroScience (2025)
Open Access

Anlotinib may have a therapeutic effect on papillary craniopharyngiomas without the BRAFv600e mutation
Yilamujiang Ainiwan, H. B. Li, Yongjia Zheng, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access

The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance
Paolo Spagnolo, Roberto Tonelli, Anna Valeria Samarelli, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 7, pp. 617-631
Closed Access | Times Cited: 24

Assessment of Exercise Capacity in Post-COVID-19 Patients: How Is the Appropriate Test Chosen?
Rodrigo Torres‐Castro, Rodrigo Núñez‐Cortés, Santiago Larrateguy, et al.
Life (2023) Vol. 13, Iss. 3, pp. 621-621
Open Access | Times Cited: 12

MicroRNA‐guided drug discovery for mitigating persistent pulmonary complications in critical COVID‐19 survivors: A longitudinal pilot study
María C. García‐Hidalgo, Iván D. Benítez, Manel Perez‐Pons, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 4

COVID-19 and Pulmonary Angiogenesis: The Possible Role of Hypoxia and Hyperinflammation in the Overexpression of Proteins Involved in Alveolar Vascular Dysfunction
Anna Flavia Ribeiro Santos Miggiolaro, Felipe Silva, David Batista Wiedmer, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 706-706
Open Access | Times Cited: 10

Trajectories of Host-Response Subphenotypes in Patients With COVID-19 Across the Spectrum of Respiratory Support
Michael Lu, Callie Drohan, William Bain, et al.
CHEST Critical Care (2023) Vol. 1, Iss. 3, pp. 100018-100018
Open Access | Times Cited: 8

A narrative review on lung injury: mechanisms, biomarkers, and monitoring
Wei Fan, Biyu Gui, Xiaolei Zhou, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 2

Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19
Tamara Cruz, Núria Mendoza, Gema M. Lledó, et al.
ERJ Open Research (2023) Vol. 9, Iss. 3, pp. 00020-2023
Open Access | Times Cited: 6

Risk Factors for Longer-Term Mortality in Discharged Patients with Dementia and SARS-CoV-2 Infection: A Matched Case-Control Study
Shanquan Chen, Rudolf N. Cardinal, Kathryn Auckland, et al.
Journal of Alzheimer s Disease (2023) Vol. 92, Iss. 1, pp. 295-309
Open Access | Times Cited: 5

ERS International Congress 2022: highlights from the Respiratory Clinical Care and Physiology Assembly
Angelos Vontetsianos, Damla Karadeniz Güven, Sophie Betka, et al.
ERJ Open Research (2023) Vol. 9, Iss. 4, pp. 00194-2023
Open Access | Times Cited: 5

Brief Research Report: Serum clara cell 16 kDa protein levels are increased in patients hospitalized for severe SARS-CoV-2 or sepsis infection
Nathalie Rohmann, Paula Stürmer, Corinna Geisler, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8

Lactate dehydrogenase contribution to symptom persistence in long COVID: A pooled analysis
Raphael Udeh, Alberto Utrero‐Rico, Xenia Dolja‐Gore, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 6
Open Access | Times Cited: 4

Aprotinin (I): Understanding the Role of Host Proteases in COVID-19 and the Importance of Pharmacologically Regulating Their Function
Juan Fernando Padín, José Manuel Pérez‐Ortiz, Francisco Javier Redondo Calvo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7553-7553
Open Access | Times Cited: 1

Vascular risk factors for COVID-19 ARDS: endothelium, contact-kinin system
Melanie J. Bailey, Dermot Linden, Hong Guo-Parke, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 3

Persistent Endothelial Lung Damage and Impaired Diffusion Capacity in Long COVID
Andreas Asimakos, Alice G. Vassiliou, Chrysi Keskinidou, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1351-1351
Open Access | Times Cited: 3

Salivary Antiviral and Antibacterial Properties in the Encounter of SARS-CoV-2
Nooshin Mohtasham, Rahimeh Bargi, Alieh Farshbaf, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 27, pp. 2140-2148
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top